US Patent Issued to Step Pharma on Nov. 11 for "N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases" (British, French Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,810, issued on Nov. 11, was assigned to Step Pharma S.A.S. (Paris).

"N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases" was invented by Abdul Quddus (Nottingham, Great Britain), Andrew Novak (Nottingham, Great Britain), David Cousin (Nottingham, Great Britain), Emma Blackham (Nottingham, Great Britain), Geraint Jones (Nottingham, Great Britain), Joseph Wrigglesworth (Nottingham, Great Britain), Lorna Duffy (Nottingham, Great Britain), Louise Birch (Nottingham, Great Britain), Pascal George (Paris) and Saleh Ahmed (...